TrialBlood2022

Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.

Matthew G Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.